Nursing
News, opinions and meeting coverage in nursing.
FDA Panel Puts Brakes on Anti-PARP Drug
WASHINGTON -- Approval of a PARP inhibitor for patients with advanced ovarian cancer should await results of an ongoing clinical trial that has the potential to answer questions about the drug's safety and efficacy, according to an FDA advisory committee that voted against immediate approval.
Jun 25, 2014
CCSVI Practices Suboptimal but Patients Don't Mind
DALLAS -- Canadian multiple sclerosis patients who left the country to undergo the controversial procedure called chronic cerebrospinal venous insufficiency (CCSVI) often received poor pre- and postoperative care, but most were still relatively satisfied overall, a researcher reported here.
Jun 01, 2014
Gastro Effects Dog Oral MS Drug Tecfidera
DALLAS -- Large proportions of patients starting on dimethyl fumarate (Tecfidera) for multiple sclerosis need additional medications to manage the drug's GI and other side effects, and a substantial minority ultimately find the drug intolerable.
May 30, 2014
Vaccines and Biologics: Questions Remain
Vaccinations for patients with autoimmune diseases -- specifically patients being treated with biologics -- bring with them a variety of issues, including disease-specific, medication-related, and vaccine-associated factors, researchers suggested.
May 24, 2014
Lung Foam Disappoints in COPD
SAN DIEGO -- A trial of hydrogel-based lung volume reduction therapy in patients with chronic obstructive pulmonary disease (COPD) complicated by emphysema failed to show consistent enough results and has been abandoned by the agent's developer, researchers said here.
May 20, 2014